Scarica l'app Stockscreener
18.38
2.00%
-0.39
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RLAY Giù?
Forum
Previsione
Relay Therapeutics Inc Borsa (RLAY) Ultime notizie
What is HC Wainwright's Estimate for RLAY FY2027 Earnings? - MarketBeat
RLAY Maintained by HC Wainwright & Co. -- Price Target Raised to $29 - GuruFocus
Relay Therapeutics (NASDAQ:RLAY) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
H.C. Wainwright raises Relay Therapeutics price target to $29 By Investing.com - Investing.com Canada
Relay Therapeutics, Inc. $RLAY Shares Bought by Bank of America Corp DE - MarketBeat
Relay Therapeutics (RLAY) Reported Q2 Results, Is The Premium P B Multiple Justified? - Yahoo Finance
Relay Therapeutics (RLAY) Stock May Be Fully Valued After A 7x Run - simplywall.st
Timothy G. Youngquist 2020 Irrevocable Trust Boosts Stake in Relay Therapeutics, Inc. $RLAY - MarketBeat
Handelsbanken Fonder AB Buys New Shares in Relay Therapeutics, Inc. $RLAY - MarketBeat
Relay Therapeutics Insider Sold Shares Worth $979,886, According to a Recent SEC Filing - marketscreener.com
Relay Therapeutics (RLAY) CEO sells 48K shares in plan trade - Stock Titan
Relay Therapeutics (RLAY) CFO sells shares via preset trading plan - Stock Titan
Relay (RLAY) Earnings Metrics: EPS Does Not Reach the Reported Estimate in Latest Trading - Vinanet
Relay Therapeutics stock hits 52-week high at 20.83 USD - Investing.com
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci - The Globe and Mail
Alphabet Inc. Makes New Investment in Relay Therapeutics, Inc. $RLAY - MarketBeat
RLAY Stock Declines Pre-Market After $175M Offering — Despite Fresh Bullish Calls On Relay's Zovegalisib - Stocktwits
Why Is RLAY Stock Rising Today? - Stocktwits
Relay Therapeutics (NASDAQ:RLAY) Sets New 52-Week High Following Analyst Upgrade - MarketBeat
Persistent Asset Partners Ltd Makes New $1.32 Million Investment in Relay Therapeutics, Inc. $RLAY - MarketBeat
Elmind Capital, LP's Relay Therapeutics Inc(RLAY) Holding History - GuruFocus
Relay Therapeutics (NASDAQ:RLAY) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
PERCEPTIVE ADVISORS LLC Expands Relay Therapeutics Inc (RLAY) St - GuruFocus
Relay Therapeutics (RLAY): Commodore Capital group discloses 12M-share, 5.5% position - Stock Titan
J.P. Morgan Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Announces Target Price $31 - Moomoo
RLAY Maintained by JP Morgan -- Price Target Raised to $31.00 - GuruFocus
Relay Therapeutics (NASDAQ:RLAY) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
Relay Therapeutics Stock Is Up Nearly 500% Over the Past Year - Barchart.com
Relay Therapeutics, Inc. $RLAY Shares Bought by California State Teachers Retirement System - MarketBeat
These Analysts Think Relay Therapeutics, Inc.'s (NASDAQ:RLAY) Sales Are Under Threat - simplywall.st
Relay Therapeutics, Inc. (NASDAQ:RLAY) Analysts Are Cutting Their Estimates: Here's What You Need To Know - webull.com
Relay Therapeutics (RLAY) Holds at $19.99 as Biotech Consolidates Between Key Support and ResistanceWyckoff Distribution - vinanet.vn
Relay Therapeutics (RLAY): Perceptive Advisors discloses 6.4% ownership stake - Stock Titan
RLAY Maintained by Citizens -- Price Target Raised to $26 - GuruFocus
Citizens Jmp Increases Relay Therapeutics (NASDAQ:RLAY) Price Target to $26.00 - MarketBeat
Relay Therapeutics, Inc. (NASDAQ:RLAY) Just Reported And Analysts Have Been Cutting Their Estimates - Moomoo
Citizens raises Relay Therapeutics stock price target on progress By Investing.com - in.investing.com
Citizens raises Relay Therapeutics stock price target on progress - Investing.com
Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Posts Quarterly Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
RLAY Maintained by Barclays -- Price Target Raised to $30.00 - GuruFocus
FMR LLC (RLAY) discloses 21.27M-share, 10% holding in Relay Therapeutics - Stock Titan
Relay Therapeutics Inc (RLAY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Relay Therapeutics, Inc. (RLAY): Investor Outlook On A Biotech With 33% Potential Upside - DirectorsTalk Interviews
Is Relay Therapeutics Inc (RLAY) Overvalued After Q2 Earnings Mi - GuruFocus
Guggenheim reiterates Buy on Relay Therapeutics stock, $26 target By Investing.com - Investing.com Canada
Relay Therapeutics president and CEO Sanjiv Patel sells $943,736 in stock - Investing.com Nigeria
Relay Therapeutics, Inc. Stock 12‑Month Price Target Raised to $26.31, Implies 33% Upside - TradingView
Relay Therapeutics Q2 Results: Sales drop 48% YoY, miss estimates - scanx.trade
Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Earnings Flash (RLAY) Relay Therapeutics Posts Q2 Loss $0.41 per Share, vs. FactSet Est of $0.39 Loss - marketscreener.com
Relay Therapeutics, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings Flash (RLAY) Relay Therapeutics, Inc. Reports Q2 Revenue $400,000 - marketscreener.com
Relay Therapeutics Q2 revenue misses estimates on higher R&D expenses; net loss widens - TradingView
Relay Therapeutics 2Q 2026: Revenue $0.35M, Net loss $83.7M, EPS $(0.41) — 10-Q Summary - TradingView
Relay Therapeutics, Inc. Quarterly Earnings Report - Stock Titan
Relay Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates - The Manila Times
Relay Therapeutics Expands ATM Program to $462.98 Million With TD Cowen; 3% Fee - TradingView
Relay Therapeutics earnings in spotlight amid trial progress By Investing.com - Investing.com Canada
Relay Therapeutics earnings in spotlight amid trial progress - Investing.com
FMR LLC and Abigail Johnson disclose 9.4% Relay Therapeutics (RLAY) ownership in 13G - Stock Titan
Dimensional Fund Advisors LP Buys 460,186 Shares of Relay Therapeutics, Inc. $RLAY - MarketBeat
1.01%
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):